Occult hepatitis B virus infection
- PMID: 17112622
- DOI: 10.1016/j.jhep.2006.10.007
Occult hepatitis B virus infection
Abstract
The persistence of hepatitis B virus (HBV) genomes in HBV surface antigen (HBsAg) negative individuals is termed occult HBV infection. Occult HBV status is associated in some cases with mutant viruses undetectable by HBsAg assays, but more frequently it is due to a strong suppression of viral replication and gene expression. Occult HBV infection is an entity with world-wide diffusion, although the available data of prevalence in various categories of individuals are often contrasting because of the different sensitivity and specificity of the methods used for its detection in many studies. Occult HBV may impact in several different clinical contexts, including the transmission of the infection by blood transfusion or organ transplantation and its acute reactivation when an immunosuppressive status occurs. Moreover, much evidence suggests that it can favour the progression of liver fibrosis and above all the development of hepatocellular carcinoma.
Similar articles
-
Occult hepatitis B virus infection: detection and significance.Dig Dis. 2010;28(1):116-25. doi: 10.1159/000282074. Epub 2010 May 7. Dig Dis. 2010. PMID: 20460899 Review.
-
Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China.J Infect. 2009 May;58(5):383-8. doi: 10.1016/j.jinf.2009.02.013. Epub 2009 Mar 29. J Infect. 2009. PMID: 19329189
-
Diagnosis of hepatitis B virus infection through serological and virological markers.Expert Rev Gastroenterol Hepatol. 2008 Aug;2(4):553-62. doi: 10.1586/17474124.2.4.553. Expert Rev Gastroenterol Hepatol. 2008. PMID: 19072403 Review.
-
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C.AIDS. 2007 Oct 18;21(16):2171-5. doi: 10.1097/QAD.0b013e3282eea504. AIDS. 2007. PMID: 18090043
-
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.Cancer. 2006 Mar 15;106(6):1326-30. doi: 10.1002/cncr.21702. Cancer. 2006. PMID: 16453330
Cited by
-
High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in Botswana.Viruses. 2024 Apr 11;16(4):592. doi: 10.3390/v16040592. Viruses. 2024. PMID: 38675933 Free PMC article.
-
Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy.Drug Saf. 2024 Apr;47(4):321-332. doi: 10.1007/s40264-024-01399-4. Epub 2024 Feb 14. Drug Saf. 2024. PMID: 38353882 Free PMC article.
-
Killer cell immunoglobulin-like receptor alleles influence susceptibility to occult hepatitis B infection in West African population.J Public Health Afr. 2023 Oct 1;14(9):2586. doi: 10.4081/jphia.2023.2586. eCollection 2023 Oct 1. J Public Health Afr. 2023. PMID: 37908389 Free PMC article.
-
Hepatitis Virus-associated Non-hodgkin Lymphoma: Pathogenesis and Treatment Strategies.J Clin Transl Hepatol. 2023 Oct 28;11(5):1256-1266. doi: 10.14218/JCTH.2022.00079S. Epub 2023 May 30. J Clin Transl Hepatol. 2023. PMID: 37577221 Free PMC article. Review.
-
Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer.Cancers (Basel). 2023 Mar 14;15(6):1766. doi: 10.3390/cancers15061766. Cancers (Basel). 2023. PMID: 36980652 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical